Introduction
Acute lung injury (ALI) and its severe manifestation, acute respiratory distress syndrome (ARDS), are lifethreatening inflammatory conditions that involve acute respiratory failure (1, 2) . Lung injury causes the release of pro-inflammatory cytokines and the recruitment of neutrophils in lung tissue (3) (4) (5) (6) . Activation of cytokines and infiltrating neutrophils damage the alveolarcapillary barrier and lead to subsequent pulmonary fibrosis (7) (8) (9) . Despite recent advances in studies of the pathogenesis of ALI and ARDS, the molecular mechanism that initiates ALI and ARDS has not been elucidated in detail.
Allograft inflammatory factor 1 (AIF-1) is a 17-kDa Ca 2+ -binding EF-hand intracellular protein that is encoded by the HLA class III genomic region (10) (11) (12) . AIF-1 was originally cloned from activated macrophages in atherosclerotic allogenic heart grafts undergoing chronic immune rejection in a rat (13) . Although the expression of AIF-1 has been noted in various tissues such as the testes, spleen, lymph nodes, lungs, thymus, and synovium, the detailed role of AIF-1 remains unclear (10, (14) (15) (16) .
The expression of AIF-1 increased two-fold in acutely rejected liver allografts in comparison to accepted liver grafts (17) . Studies have shown that expression of AIF-1 increased in a model of trinitrobenzene sulfonic acid-induced acute colitis and in acute cellular rejection of cardiac allografts (18, 19) . In vitro, CRL-2192 (a rat macrophage cell line) expressed a certain level of endogenous AIF-1, and this expression was enhanced with the pro-inflammatory cytokines IL-1β and TNF-α (20) . AIF-1-transfected CRL-2192 cells had enhanced levels of monocyte chemoattractant protein 1 and enhanced cell migration (20) . AIF-1-transfected RAW 264.7 cells had enhanced production of the inflammatory cytokines IL-6 and IL-12 as a result of stimulation with a lipopolysaccharide (21) . These findings suggest that AIF-1 plays a crucial role in the mechanism of inflammation. The present study used a model of bleomycin-induced lung injury to examine the expression and function of AIF-1 in ALI.
Materials and Methods

Bleomycin-induced ALI
C57BL/6 mice (8-10 weeks of age) were purchased from Shimizu Laboratory Supplies Co., Ltd. Mice were anesthetized by intraperitoneal administration of pentobarbital. Thirty μL of bleomycin hydrochloride (Nippon Kayaku Co, Tokyo, Japan) solution containing 2.15 U/kg of bleomycin dissolved in sterile saline was injected directly into the trachea using a 0.9-mm feeding needle (KN-348 Natsume Seisakusho Co., Tokyo, Japan). Control mice received the same volume of sterile saline alone. Mice were sacrificed on Day 1 by intraperitoneal administration of excess pentobarbital (120-150 mg/kg). Mice were euthanized if their body weight fell below 80% of that measured at the baseline. The study was approved by the Animal Research Committee, Graduate School of Medical Science, Kyoto Prefectural University of Medicine.
Histology
The lungs were excised on Day 1 after intratracheal administration of bleomycin and immediately fixed with 4% paraformaldehyde. The samples were then embedded in paraffin and stained with hematoxylin and eosin (H&E) method. Images were acquired using a DMBA210 microscope (Shimadzu Rika, Tokyo, Japan) equipped with Motic Images Plus2.2s software (Shimadzu Rika).
Immunohistochemical analysis
The lungs were excised on Day 1 after intratracheal administration of bleomycin and immediately fixed with 4% paraformaldehyde. Paraffin-embedded sections were deparaffinized in xylol and rehydrated through a graded series of ethanol solutions. Endogenous peroxidase was blocked by incubation in 3% H 2 O 2 for 30 min. Sections were stained with anti-AIF-1 antibody (Sigma) (1:150), anti-F4/80 antibody (Serotec) (1:100) or normal goat IgG isotype control overnight followed by MAX-PO (Nitirei Bioscience) for 30 min. Finally, sections were stained with diaminobenzidine (Nitirei Bioscience). All sections were counterstained with hematoxylin for 2 min.
Bronchoalveolar lavage fluid (BALF)
BALF analyses were performed on Day 1 after intratracheal administration of bleomycin as previously described (22) . Briefly, the lungs and trachea were exposed and a 20-gauge intravenous catheter was inserted into the trachea. A total of 1 mL of PBS was instilled three times and withdrawn from the lungs via an intratracheal cannula. More than 95% of the fluid was recovered as BALF, which was then centrifuged at 1,000 rpm for 5 min at 4°C. The supernatant was collected and stored at -80°C for use in ELISA. The levels of AIF-1, IL-6, TNF-α, and KC in the BALF were measured using commercial ELISA kits (an AIF-1 ELISA kit; USCN Lifescience, an IL-6 ELISA kit and a TNF-α ELISA kit; eBioscience, an KC ELISA kit; R&D Systems), according to the manufacturer's instructions. The optical density was measured at 450 nm using a SoftMaxPro40 plate reader. Each measurement was determined in three separate experiments on BALF. The total number of cells in BALF was counted using a Fuchs-Rosenthal hemocytometer (ERMA Inc., Tokyo, Japan). The BALF solution was placed in a cytospin (Cytospin 2; Shandon Inc., Pittsburgh, PA, USA), centrifuged at 700 rpm for 10 minutes, and stained with Diff-Quick (Sysmex, Kobe, Japan). The number of total cells, neutrophils, and macrophages were counted. At least 200 cells per slide were evaluated on the basis of morphological criteria using a light microscope.
Isolation of primary lung fibroblasts
Primary lung fibroblasts were isolated from C57BL/6 mice and cultured as previously described (23, 24) . Briefly, normal C57BL/6 mice (8-10 weeks-of-age) were sacrificed by intraperitoneal administration of excess pentobarbital and lung tissue was promptly collected, washed with phosphate buffered saline (PBS), and cut into approximately 2.0-mm 3 blocks. The blocks were seeded onto the bottom of a culture flask containing RPMI 1640 medium (Wako, Osaka, Japan) supplemented with 10% FBS, 100 U/mL penicillin, and 100 mg/mL streptomycin, and the fibroblasts were cultured at 37°C in a 5% CO 2 incubator. The medium was changed every 2-3 days. Lung fibroblasts from three to five passages were used for all experiments.
Cell culture
A mouse macrophage cell line, RAW 264.7, was obtained from the RIKEN cell bank (Tsukuba, Japan). RAW264.7 cells were seeded in 12-well plates (5 × 10 5 cells/well) and primary lung fibroblasts were seeded in 12-well plates (2 × 10 5 cells/well) in RPMI-1640 supplemented with 10% FBS for 24 h. Media were replaced with serum-free RPMI-1640 and the cells were serum-starved overnight. Next, the cells were stimulated for 24 h by addition of RPMI-1640 supplemented with various concentrations of recombinant AIF-1 (CUSABIO, endotoxin removed) or a lipopolysaccharide (LPS) (Sigma). The cell culture supernatant was collected and stored at -80°C until required. The levels of IL-6, TNF-α round with round nuclei and that expressed AIF-1 were evident in lung tissue after treatment with bleomycin ( Figures 2B and 2F ). Invasive macrophages (arrow head) that were mostly round with round nuclei and that expressed F4/80 were evident in lung tissue after treatment with bleomycin ( Figures 2D and 2H) . These results indicate that AIF-1 was expressed in invasive macrophages. Immunostaining of lung tissue with normal IgG was completely negative after treatment with bleomycin ( Figures 2C and 2G ).
and KC in the cell culture supernatant were measured using commercial ELISA kits. The optical density was measured at 450 nm using a SoftMaxPro40 plate reader. Each measurement was determined in three separate experiments.
Quantitative real-time RT-PCR analyses
On Day 1 after intratracheal administration of saline or bleomycin, cells were seeded at a concentration of 1 × 10 5 cells/well in 24-well plates and cells were incubated in RPMI-1640 supplemented with 10% FBS for 24 h. The next day, the medium was washed with PBS three times and only cells adhering to the bottom of plates (alveolar macrophages) were collected. Total RNA was obtained from the macrophages with an RNeasy Plus Mini Kit (Qiagen). Quantitative real time RT-PCR was performed on StepOne™ & StepOnePlus™ Real-Time PCR Systems (Life Technologies) using the Thunderbird Probe qPCR Mix (TOYOBO). The following TaqMan expression assays were used: Mm00479862_g1 (AIF-1), Mm99999915_g1 (GAPDH). Results in duplicate were normalized to GAPDH expression. Data are expressed as the mean -fold change relative to control samples.
Statistical analysis
Results are expressed as either the mean ± SEM or the median as appropriate. All values were analyzed with a Mann-Whitney U test. p values < 0.05 were considered statistically significant.
Results
Inflammatory cells increased in lung tissue and BALF from mice with bleomycin-induced ALI
To estimate the degree of inflammation in lung tissue after treatment with saline or bleomycin, tissue samples were stained with H&E. Lung tissue from mice exposed to bleomycin on Day 1 displayed severe inflammation in comparison to tissue from the control group ( Figures  1A-1D) . BALF from mice exposed to bleomycin showed that the total cell number and the number of neutrophils and macrophages on Day 1 increased in comparison to numbers in the control group ( Figure  1E ).
AIF-1 is expressed in lung tissue from mice with bleomycin-induced ALI
To estimate the expression of AIF-1 in lung tissue on Day 1 after treatment with saline or bleomycin, samples were stained with an anti-AIF-1 Ab or anti-F4/80 Ab. Cells expressing AIF-1 were not evident in lung tissue after treatment with saline (Figures 2A and 2E) . In contrast, invasive cells (arrow head) that were mostly 
AIF-1 is expressed in BALF and alveolar macrophages in BALF from mice with bleomycin-induced ALI
To examine the expression of AIF-1 in BALF on Day 1 after treatment with saline or bleomycin, the concentration of AIF-1 was measured using ELISA. In BALF, the level of AIF-1 expression was significantly increased in comparison to that in the control group ( Figure 3A) . The expression of AIF-1 was examined in alveolar macrophages from BALF. Real-time PCR analysis indicated that the level of AIF-1 mRNA was significantly increased in alveolar macrophages from BALF on Day 1 after intratracheal administration of bleomycin in comparison to administration of saline ( Figure 3B ).
AIF-1 stimulates RAW264.7 cells and lung fibroblasts to secrete IL-6 and TNF-α
To estimate the levels of inflammatory cytokines in BALF after treatment with saline or bleomycin, the levels of IL-6 and TNF-α were measured. BALF from mice exposed to bleomycin on Day 1 displayed significantly increased levels of IL-6 and TNF-α in comparison to levels in the control group ( Figures 3A  and 4B ). The effect of recombinant AIF-1 on cytokine secretion by RAW264.7 cells and lung fibroblasts was examined in vitro. Cultured RAW264.7 cells and lung fibroblasts were stimulated for 24 h with various concentrations of recombinant AIF-1 or LPS. The levels of IL-6 and TNF-α secreted by AIF-1 (10 ng/mL-1 µg/ mL)-treated RAW264.7 cells were significantly higher than those secreted by control cells, and this effect was dose-dependent ( Figures 4C and 4D) . The levels of IL-6 and TNF-α secreted by AIF-1-treated lung fibroblasts were also significantly higher than those secreted by control cells, and this effect was also dose-dependent ( Figures 4E and 4F ).
AIF-1 stimulates lung fibroblasts to secrete KC
The number of neutrophils in BALF increased on Day 1 after mice were exposed to bleomycin ( Figure 1E ). The concentration of KC, which is involved in chemotaxis and cell activation of neutrophils, was measured next. BALF from mice exposed to bleomycin on Day 1 had a significantly increased level of KC in comparison to control cells ( Figure 5A ). The effect of recombinant AIF-1 on chemokine secretion by lung fibroblasts was examined in vitro. Cultured lung fibroblasts were stimulated for 24 h with various concentrations of recombinant AIF-1 or LPS. The level of KC secreted by AIF-1 (10 ng/mL-1 µg/mL)-treated lung fibroblasts was significantly higher than that secreted by control cells, and this effect was dose-dependent ( Figure 5B ). Recombinant AIF-1 did not stimulate the secretion of KC from RAW264.7 cells (data not shown).
Discussion
The current study has shown that AIF-1 was expressed in lung macrophages and increased in BALF from mice with bleomycin-induced ALI. This study also showed that recombinant AIF-1 stimulated the secretion of IL-6 and TNF-α in RAW264.7 cells and lung fibroblasts and it stimulated the secretion of KC in lung fibroblasts.
Taken together, these findings suggest that AIF-1 plays an important role in the mechanism underlying the etiology of ALI.
AIF-1 was expressed in macrophages in lung tissue with bleomycin-induced ALI. Evidence of AIF-1 expression in macrophages coincides with previous studies that detected AIF-1 in macrophages in a model of atherosclerotic allogenic heart grafts or in human macrophage-like cell lines (13, 25) . AIF-1 was also expressed in BALF from mice with bleomycin-induced ALI. These results suggest that AIF-1 was produced by lung macrophages in bleomycin-induced ALI and that AIF-1 may play a role in the mechanism of inflammation.
Bleomycin induces inflammatory changes in lung tissue with increased expression of pro-inflammatory cytokines in a short period of time (26) . In the current study, levels of IL-6 and TNF-α were significantly increased in BALF from mice exposed to bleomycin in comparison to the control group on Day 1. Both IL-6 and TNF-α are known to be crucial pro-inflammatory cytokines that have variable biological effects on inflammation, immune responses, cell differentiation and proliferation, hematopoiesis, and oncogenesis (27) (28) (29) . The current study also indicated that recombinant AIF-1 stimulates the production of IL-6 and TNF-α from a macrophage cell line (RAW264.7) and lung fibroblasts in vitro. Although the biological function of lung macrophages has not been completely elucidated and additional research is needed to clarify the role that AIF- 1 plays, the current results suggest that AIF-1 is produced by lung macrophages and that lung macrophages might produce IL-6 and TNF-α as autocrines.
A study has reported that fibroproliferative activity is present in the early phase in lungs of patients with ARDS (30) . Histology has also indicated that fibroproliferation is present in the early phase in the lungs of patients with ARDS (31,32). As indicated above, lung fibroblasts are thought to play an important role in ALI. Previous studies by the current authors demonstrated that recombinant AIF-1 can stimulate the secretion of IL-6 in human synoviocytes and normal human dermal fibroblasts (16, 33) . However, lung fibroblasts secreted TNF-α in addition to IL-6 when stimulated with recombinant AIF-1. These results suggest that AIF-1 produced by lung macrophages contributes to the development of bleomycin-induced ALI by inducing the production of IL-6 and TNF-α by stimulating lung macrophages in an autocrinal manner and by stimulating lung fibroblasts in a paracrinal manner.
Another interesting finding from the current study is that the expression of KC and the number of neutrophils were significantly increased in BALF from mice exposed to bleomycin in comparison to the control group. KC (CXCL1) has been proposed as a functional homologue of human IL-8 and is associated with neutrophil recruitment and inflammation (34) . The level of IL-8 in BALF is reported to be significantly higher in patients who subsequently develop ARDS than in patient who do not develop ARDS (35, 36) . Ma et al. showed that the level of KC in BALF was elevated on Day 1 after intratracheal administration of bleomycin (37) . These results coincide with the current finding. Moreover, the current study also indicated that recombinant AIF-1 stimulated the secretion of KC in lung fibroblasts. These results suggest that AIF-1 contributes to the recruitment of neutrophils by inducing the production of KC by lung fibroblasts in bleomycininduced ALI.
In conclusion, the current study showed that AIF-1 was overexpressed in lung macrophages and increased in BALF from mice with bleomycin-induced ALI. AIF-1 can stimulate the secretion of IL-6 and TNF-α in macrophages and lung fibroblasts. This study also indicated that KC, a chemokine that induces neutrophil recruitment and inflammation, is secreted in lung fibroblasts stimulated with AIF-1. These findings suggest that AIF-1 plays a critical role in the mechanism underlying the etiology of ALI.
